These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36384435)

  • 1. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP).
    Bell JM; Lubian AF; Partridge SR; Gottlieb T; Robson J; Iredell JR; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2022 Nov; 46():. PubMed ID: 36384435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2022.
    Bell JM; Fajardo Lubian A; Partridge SR; Gottlieb T; Robson J; Iredell JR; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2023 Nov; 47():. PubMed ID: 37968067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2017.
    Bell JM; Gottlieb T; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2019 Aug; 43():. PubMed ID: 31426735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GnSOP) Annual Report 2020.
    Bell JM; Lubian AF; Partridge SR; Gottlieb T; Iredell J; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2022 Mar; 46():. PubMed ID: 35382709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2018.
    Bell JM; Gottlieb T; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2020 Oct; 44():. PubMed ID: 33081651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2019.
    Bell JM; Lubian AF; Partridge S; Gottlieb T; Iredell J; Daley DA; Coombs GA
    Commun Dis Intell (2018); 2020 Oct; 44():. PubMed ID: 33081652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2016.
    Bell JM; Gottlieb T; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30626303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme(GNSOP) Annual Report 2015.
    Bell JM; Gottlieb T; Daley DA; Coombs GW;
    Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30632360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2015.
    Coombs GW; Daley DA; Lee YT; Pang S; Bell JM; Turnidge JD;
    Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30632361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian Group on Antimicrobial Resistance Australian Enterobacteriaceae Sepsis Outcome Programme annual report, 2014.
    Bell JM; Turnidge JD; Coombs GW; Daley DA; Gottlieb T; Robson J; George N
    Commun Dis Intell Q Rep; 2016 Jun; 40(2):E229-35. PubMed ID: 27522134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Australian Group on Antimicrobial Resistance Community-onset Gram-negative Surveillance Program annual report, 2010.
    Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Pearson JC; Bell JM;
    Commun Dis Intell Q Rep; 2013 Sep; 37(3):E219-23. PubMed ID: 24890957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.
    Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E327-33. PubMed ID: 25631595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-onset Gram-negative Surveillance Program annual report, 2012.
    Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
    Commun Dis Intell Q Rep; 2014 Mar; 38(1):E54-8. PubMed ID: 25409356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital-onset Gram-negative Surveillance Program annual report, 2011.
    Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Pearson JC; Bell JM;
    Commun Dis Intell Q Rep; 2014 Mar; 38(1):E49-53. PubMed ID: 25409355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of Plasmid Mediated mcr Colistin Resistance Gene in Clinical Enterobacterales Isolates].
    Özkaya E; Buruk CK; Tosun İ; Toraman B; Kaklıkkaya N; Aydın F
    Mikrobiyol Bul; 2020 Apr; 54(2):191-202. PubMed ID: 32723275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-susceptibilities to antibiotics against important Gram-negative bacteria, and imipenem-relebactam, meropenem-vaborbactam against carbapenem non-susceptible Enterobacterales and Pseudomonas aeruginosa isolates implicated in complicated intra-abdominal and urinary tract infections in Taiwan, 2019.
    Jean SS; Lu MC; Ho MW; Ko WC; Hsueh PR;
    Int J Antimicrob Agents; 2022 Mar; 59(3):106521. PubMed ID: 35066144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018.
    Jean SS; Lee YL; Liu PY; Lu MC; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2022 Jun; 55(3):463-473. PubMed ID: 34503920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian Group on Antimicrobial Resistance surveillance outcome programs - bloodstream infections and antimicrobial resistance patterns from patients less than 18 years of age, January 2020 - December 2021.
    Williams A; Coombs GW; Bell J; Daley DA; Mowlaboccus S; Bryant PA; Campbell AJ; Cooley L; Iredell J; Irwin AD; Kesson A; McMullan B; Warner MS; Williams P; Blyth CC
    Commun Dis Intell (2018); 2024 Aug; 48():. PubMed ID: 39165021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin-Tazobactam Susceptibility Testing of
    García-Fernández S; Bala Y; Armstrong T; García-Castillo M; Burnham CA; Wallace MA; Hardy D; Zambardi G; Cantón R
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31597745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection.
    Candel FJ; Santerre Henriksen A; Longshaw C; Yamano Y; Oliver A
    Clin Microbiol Infect; 2022 Mar; 28(3):447.e1-447.e6. PubMed ID: 34298176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.